OptimizeRx Reports Reduced Q1 Loss, Achieves Operating Income, Details Debt Refinancing

summarizeSummary

OptimizeRx reported significantly reduced Q1 net loss and achieved operating income, alongside detailing a new $35 million debt refinancing that improves liquidity and reduces interest costs.

check_boxKey Events

• Reduced Net Loss and Achieved Operating Income

  OptimizeRx significantly reduced its net loss to $495,000 in Q1 2026 from $2.2 million in Q1 2025, and shifted from an operating loss of $2.1 million to an operating income of $396,000.

• Completed Debt Refinancing

  The company completed a debt refinancing on May 7, 2026, securing a new $25 million term loan and a $10 million unsecured revolving credit facility, which repays the previous Term Loan and is projected to save $1.5 million annually in interest.

• Revenue Decline with Strategic Shift

  Net revenue decreased by 10% to $19.8 million, primarily due to exiting a low-margin managed service program and a customer loss, as the company strategically shifts focus to higher-margin solutions.

• Chief Commercial Officer Departure

  Theresa Greco, the Chief Commercial Officer, will mutually separate from the company effective June 15, 2026.

auto_awesomeAnalysis

OptimizeRx's Q1 2026 results show a significant improvement in profitability, moving from an operating loss of $2.1 million in Q1 2025 to an operating income of $396,000. The net loss also substantially decreased from $2.2 million to $495,000. This financial turnaround, coupled with the recently completed $35 million debt refinancing (a $25 million term loan and $10 million revolving credit facility), strengthens the company's liquidity and reduces future interest expenses. While revenue declined by 10% due to a strategic exit from low-margin services and a customer loss, the shift towards higher-margin solutions is intended to improve overall profitability. The ongoing material weakness in internal controls and the upcoming departure of the Chief Commercial Officer introduce elements of risk and uncertainty.